Sale!

Sartanos 20mg (Telmisartan) – 100 Tabs

Original price was: 35,67 €.Current price is: 31,23 €.

SARTANOS 20 MG DRIADA MEDICAL (TELMISARTAN) DESCRIPTION Telmisartan is an antihypertensive agent, an angiotensin II receptor antagonist (Typ AT1). It has a very high affinity for this receptor subtype. Telmisartan displaces angiotensin II from binding to AT1 receptors. An affinity for other subtypes of AT receptors was not found. The functional significance of other receptor subtypes and the effect of increased angiotensin II levels (as a result

Category:

Description

SARTANOS 20 MG DRIADA MEDICAL (TELMISARTAN) DESCRIPTION

Telmisartan is a blood pressure medication, an angiotensin II receptor antagonist (AT1 type). It has a very high affinity for this receptor subtype. Telmisartan displaces angiotensin II from binding to AT1 receptors. No affinity for other subtypes of AT receptors was found. The functional significance of other receptor subtypes and the effect of increased angiotensin II levels (as a result of taking telmisartan) are not known.

The renin-angiotensin-aldosterone system (RAAS) is responsible for regulating blood pressure and fluid balance. It regulates the body’s response to substances like angiotensin, a naturally occurring chemical that can narrow blood vessels and increase blood pressure. A specific type of angiotensin—specifically angiotensin II—is particularly relevant here, since the use of anabolic steroids increases the levels of this specific hormone.
Telmisartan lowers plasma aldosterone levels, but does not inhibit plasma renin, does not block ion channels, and does not inhibit ACE (kininase II), which also breaks down bradykinin. Therefore, there are no side effects associated with bradykinin.
The blockade of the renin-angiotensin system with ACE inhibitors, which inhibit the biosynthesis of angiotensin II from angiotensin I, is often used in the treatment of high blood pressure. ACE inhibitors also inhibit the breakdown of bradykinin, a reaction that is also catalyzed by ACE. Since ACE (kininase I) is not inhibited, it has no influence on the response to bradykinin. Whether this difference has clinical relevance is not yet known. Telmisartan does not bind to or block other hormone receptors or ion channels known to be important for cardiovascular regulation. The blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and circulating angiotensin II levels do not diminish the blood pressure-lowering effect of telmisartan.

Use for Sartanos 20 mg Driada Medical (Telmisartan)

Telmisartan reduces left ventricular hypertrophy (LVH) and reduces visceral fat. This should be of particular interest to athletes. LVH is an adaptive response to intensive strength training, the effect of which is reinforced by the use of steroids. LVH is generally harmless among highly trained athletes; however, it is associated with reduced heart function, especially as the athlete ages. A reduction in visceral fat is also accompanied by a lower cardiovascular risk. The use of telmisartan is a scientifically proven method for damage reduction, which lowers overall mortality and, in particular, the risk of cardiovascular diseases.

Pharmacokinetics of Telmisartan

When taken orally, it is rapidly absorbed from the gastrointestinal tract. Bioavailability is 50%. If taken with food, the AUC decreases by 6% (with a 40 mg dose) to 19% (with a 160 mg dose). Three hours after intake, plasma concentration levels off, regardless of whether it is taken with a meal or on an empty stomach. Plasma protein binding is 99.5%. The average values of the apparent Vd at steady state are 500 L. It is metabolized by conjugation with glucuronic acid. Metabolites are pharmacologically inactive. T1/2 – more than 20 hours. It is excreted unchanged via the intestines. Cumulative excretion through the kidneys is less than 1%. Total plasma clearance – 1000 ml/min (renal blood flow – 1500 ml/min).

How to apply Sartanos 20 mg Driada Medical (Telmisartan)?

For adults, the daily dose is 20-40 mg (once a day). In some patients, the blood pressure-lowering effect can already be achieved with a dose of 20 mg/day. If necessary, the dose can be increased to 80 mg/day.

In patients with impaired kidney function and in older patients, no dose adjustment is required.
For patients with impaired liver function, the recommended daily dose is 40 mg.
The doses for athletes are the same: a daily dosage of 20 to 40 mg once a day to reduce the risk of arteriosclerosis, cardiovascular diseases, and/or strokes in bodybuilders using steroids. This can also improve HDL cholesterol, insulin sensitivity, mitochondrial activity, endothelial function, and cognitive function.

Positive effects

  • Treats arterial hypertension
  • Reduces cardiovascular risk
  • Improves HDL cholesterol
  • Improves insulin sensitivity
  • Increases mitochondrial activity
  • Improves endothelial function
  • Improves cognitive function
  • Reduces left ventricular hypertrophy (LVH)
  • Reduces visceral fat
  • Reduces water retention
  • Reduces adrenaline production, which causes vasoconstriction of blood vessels

Sartanos side effects 20 mg Driada Medical (Telmisartan)

  • Side effects of Telmisartan are rare and can include the following:
  • Vision changes
  • Dizziness, lightheadedness, or fainting
  • Rapid heartbeat
  • Severe hives
  • Pain when urinating or changes in the urge to urinate
  • Swelling of the hands, lower legs, and feet

Steroid profile

  • Half-life: 24 hours
  • Frequency of intake: 1-2 times a day

Contraindications

  • Low blood pressure (hypotension)
  • Pregnancy
  • If pregnancy is detected, telmisartan tablets should be discontinued as soon as possible.

How to store Telmisartan?

  • Keep away from children
  • Store in a cool, dry place out of direct sunlight
  • Store at 25 °C (77 °F); excursions permitted between 15 °C – 30 °C (59° – 86°F)
  • Do not use after the expiration date